Evidence map›Paper›PMID 42367542›Full record

ArticleCureus2026

Premature Myocardial Infarction in Severe Hypothyroidism: A Case Report.

Tambi Isaac, Khatun Mstkhaleda, Roxana Lazarescu, Samy Matta

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tambi IsaacMedical Academy, Kabardino-Balkarian State University, Nalchik, RUS.
Khatun MstkhaledaInternal Medicine, Wyckoff Heights Medical Center, New York, USA.
Roxana LazarescuInternal Medicine, Wyckoff Heights Medical Center, New York, USA.
Samy MattaInternal Medicine, Alexandria University, Alexandria, EGY.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypothyroidism exerts significant effects on the cardiovascular system through alterations in lipid metabolism, endothelial function, vascular resistance, and myocardial performance. Both overt and subclinical hypothyroidism have been associated with an increased risk of atherosclerosis and premature coronary artery disease, particularly in women and in individuals with markedly elevated thyroid‑stimulating hormone (TSH) levels. We report the case of a 60‑year‑old woman with long‑standing hypothyroidism, noncompliant with levothyroxine therapy for about six months before presentation. The patient arrived at the emergency department with acute substernal chest pain and was found to have a rapidly rising high‑sensitivity troponin level, which peaked at 125,000, with no ST elevation on electrocardiogram (ECG), consistent with non-ST‑elevation myocardial infarction (NSTEMI). Coronary angiography revealed a critical proximal left anterior descending artery occlusion requiring percutaneous coronary intervention. Echocardiography demonstrated reduced left ventricular ejection fraction (15-20%) and elevated left ventricular end‑diastolic pressure (>16 mmHg), indicating combined systolic and diastolic dysfunction. Thyroid function testing confirmed profound hypothyroidism (TSH >500). This case illustrates the multifactorial cardiovascular consequences of untreated hypothyroidism and highlights its potential association in precipitating premature ischemic events, even in the absence of traditional cardiovascular risk factors. The patient's presentation aligns with established pathophysiologic mechanisms linking thyroid hormone deficiency to endothelial dysfunction, dyslipidemia, increased systemic vascular resistance, and myocardial impairment. This report emphasizes the importance of recognizing hypothyroidism as a modifiable contributor to cardiovascular disease. Routine assessment of thyroid function should be considered in patients presenting with acute coronary syndromes, particularly when traditional risk factors are absent or insufficient to explain the severity of the disease. Early diagnosis and adherence to thyroid hormone replacement therapy may reduce cardiovascular risk and prevent serious complications.

Indexed as

accelerated atherosclerosiscoronary artery diseasehypothyroidismhypothyroidism and atherosclerosismyocardial infarction

Identifiers

PMID42367542
PMCPMC13306658

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.